Abstract

Genome editing is a crucial technology for obtaining desired phenotypes in a variety of species, ranging from microbes to plants, animals, and humans. With the advent of CRISPR-Cas technology, it has become possible to edit the intended sequence by modifying the target recognition sequence in guide RNA (gRNA). By expressing multiple gRNAs simultaneously, it is possible to edit multiple targets at the same time, allowing for the simultaneous introduction of various functions into the cell. This can significantly reduce the time and cost of obtaining engineered microbial strains for specific traits. In this review, we investigate the resolution of multiplex genome editing and its application in engineering microorganisms, including bacteria and yeast. Furthermore, we examine how recent advancements in artificial intelligence technology could assist in microbial genome editing and engineering. Based on these insights, we present our perspectives on the future evolution and potential impact of multiplex genome editing technologies in the agriculture and food industry.
Keywords: multiplex genome editing, Cas nuclease, base editor, microbial production, guide RNA
1. Introduction
Living organisms develop and change according to the organism-specific genetic information programmed in the genome. Genome editing is an essential technology for altering genetic information in order to acquire desired phenotypes. By observing the genotype–phenotype changes, it is possible to study the principles of life phenomena, such as understanding the function of specific genes and verifying the interactions between genes. In addition to basic research, genome editing technology enables the development of environmental stress-resistant seeds,1 bioproduction of food additives and cosmetic ingredients,2 creation of animal models,3 and gene therapy.4
Since the development of the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated proteins (Cas) technology, the field of genome editing has been advancing rapidly. The CRISPR-Cas system functions like a pair of genetic scissors, capable of cutting the target nucleic acid sequence by altering the target recognition sequence (TRS) of CRISPR RNA (crRNA).5 Unlike zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) that require protein engineering for recognition of wanted target DNA sequences, crRNA can be easily designed and modified.6 This flexibility has enabled the wide use of CRISPR-Cas technology in genome editing of almost all organisms, from bacteria to yeast, fungi, plants, insects, animals, and humans.7−13 To expedite genome editing, the multiplex editing method is being employed, enabling simultaneous editing at two or more loci in the genome (Figure 1). This approach reduces repeated plasmid integration, recombination processes, cost, and labor.
Figure 1.
Procedures of classical genome editing and multiplex CRISPR-Cas genome editing methods. (A) The classical genome editing approach requires multiple suicide vectors, with two crossover events necessary to achieve a single target edit. (B) The multiplex CRISPR-Cas genome editing method uses a singular plasmid encoding multiple guide RNAs, enabling the attainment of desired multiple edits in a single mutagenesis round. AbR, antibiotic resistance marker; CSM, counter-selectable marker; ori, the origin of replication.
Multiplex genome editing is highly efficient in microbial strain engineering. For instance, microbial strains with increased production of target products are obtained through random mutagenesis or directed evolution (Figure 2A,B). Random mutagenesis often leads to the accumulation of unwanted mutations unrelated to the productivity, thereby decreasing the performance of the evolved strain.14 Unnecessary mutations can be restored to the wild-type, or necessary mutations can be transferred to another background to obtain a new strain with improved productivity like inverse metabolic engineering (Figure 2C).15 By using multiplex genome editing in this process, the new strain can be produced in a time- and cost-efficient manner. Most of the mutations that occur through chemical mutagenesis and adaptive evolution are point mutations;16,17 therefore, precise modification from mutations to the desired sequences requires accurate multiplex genome editing technology.
Figure 2.
Microbial strain engineering for higher productivity through multiplex genome editing. (A) The wild-type strain showed a low yield of product ([P]/OD). (B) Evolved strain showed higher yield but slower growth, probably due to many nonspecific random mutations in the genome. (C) Transfer of beneficial mutations to new background or removal of unwanted mutations in the evolved cells, resulting in higher productivity ([P]/OD*t) in engineered cells. OD, optical density; [P], yield of product.
In this review, we summarize the current status of multiplex genome editing using CRISPR-Cas technology in bacteria and yeast. Our main emphasis lies in discussing editing resolution and the selection of suitable tools for multiplex editing. Additionally, we discuss the biochemical production in strains engineered through multiplex CRISPR-Cas genome editing. Lastly, we explore the integration of artificial intelligence (AI) with CRISPR-Cas genome editing tools and anticipate the future development of multiplex genome editing for practical applications, including agriculture and food production.
2. CRISPR-Cas-Mediated Genome Editing Methods
In the CRISPR-Cas system, the guide RNA (gRNA) recognizes the target sequence, while the protospacer-adjacent motif (PAM) sequence is recognized by Cas nuclease. Subsequently, the gRNA-Cas nuclease complex cleaves the phosphodiester bonds of the DNA target, resulting in a double-strand break (DSB) (Figure 3A).5 When DSB is repaired by non-homologous end joining (NHEJ), then all cells are not repaired identically. Random insertions and deletions (indels) can occur during NHEJ.18 To introduce specific genetic modifications such as point mutations, small modifications, and large indels, a donor template DNA should be provided so that the DSB is repaired through homology-directed repair (HDR).19
Figure 3.
Genome editing tools derived from the CRISPR-Cas system. (A) The Cas nuclease introduces double-stranded breaks at specific DNA target sites, which are subsequently repaired via non-homologous end joining (NHEJ) or homology-directed repair (HDR), facilitating targeted genomic alterations. The guide RNA (gRNA) directs the Cas nuclease to the target site. (B) The base editor consists of a Cas nickase that induces single-stranded DNA breaks, coupled with a deaminase enzyme. This enzyme catalyzes the deamination of target nucleotides within a defined editing window, leading to precise base pair substitutions. (C) The prime editor comprises a Cas nickase, a reverse transcriptase, and a prime editing guide RNA (pegRNA). This system uses the pegRNA as a template to introduce desired mutations directly into the target DNA sequence.
Base editors were developed to edit targets without causing DSB.20,21 A base modifying enzyme such as deaminase is linked to a Cas9 protein moiety, either catalytically deactivated Cas9 nuclease or Cas9 nickase (Cas9n) (Figure 3B). In addition to Cas9, the Cas12 family has been employed in the development of base editors.22 Base editors facilitate nucleotide substitutions within the editing window through the action of adenine or cytosine deaminases. Efforts to increase editing efficiency have continued through the utilization of deaminase variants and Cas9 variants obtained via laboratory evolution.23−25 Recently, dual base editors have been used to perform both adenine and cytosine conversions.26−28 Due to their lack of causing DSBs, base editors exhibit low cytotoxicity and offer the advantage of not requiring donor template DNA, thus making them widely used in various microbes.29
A prime editor, which utilizes RNA as a template, has been developed, enabling precise editing to introduce all types of point mutations (Figure 3C).30 The reverse transcriptase linked to Cas nickase forms a complex with the prime editing guide RNA (pegRNA) and facilitates editing on the nontarget strand. Although prime editors have the advantage of being capable of installing any base-to-base changes, they are not widely used in multiplex genome editing. The reasons seem to be that prime editor requires a relatively complex pegRNA design and has a lower editing efficiency.31 Therefore, we have summarized the multiplex editing of microbial genomes achievable with Cas nuclease and base editors.
3. Multiplex Microbial Genome Editing by Cas Nuclease
By introducing multiple gRNAs and Cas nuclease into a cell, multiple targets in the genome can be edited simultaneously. The first attempt at multiplex genome editing in microbes using CRISPR-Cas technology was made in Streptococcus pneumoniae, simultaneously knocking out two genes with 75% efficiency.32 Subsequently, it was reported that two or three genes could be simultaneously edited, with efficiencies of 43% and 19%, respectively, in the eukaryotic microorganism Saccharomyces cerevisiae.33 There were many cases of knocking out genes by deletion in bacteria34 and integrating several kilobase-heterologous genes in yeast.35
In the plant pathogenic bacterium Xanthomonas oryzae, a crRNA array method has been proposed to simultaneously and efficiently knock out two virulence genes by overexpressing the proteins involved in NHEJ such as Ku and LigD.36 In yeast, there have been reports that multiple sites can be edited simultaneously by introducing identical synthetic gRNA binding sites into the genome37−39 or by cutting with gRNA recognizing common sequences among different genes.40 In Ogataea thermomethanolica, Ogataea parapolymorpha, Komagataella phaffii, Scheffersomyces stipitis, and Yarrowia lipolytica, which have a preference for NHEJ, two to four targets can be knocked out without donor template DNAs.41−46
While editing the genome at a resolution of 2–4 nt in bacteria was often reported (Table 1), cases of single-nucleotide-level multiplex genome editing were hard to find.47,48 In yeast, a few cases of multiplex editing at a single-nucleotide resolution are known.49,50 Accuracy of editing is important for correcting frameshift mutations, introducing point mutations, changing amino acid residues in polypeptide chains, and optimizing ribosome binding sites (RBSs). However, the CRISPR-Cas system, with its mismatch tolerance, can cleave both edited and unedited targets, leading to the death of edited cells and hindering the negative selection of single-nucleotide-edited cells.51 One approach to overcoming this inherent characteristic of the CRISPR-Cas system is by using maximally truncated single-guide RNAs (sgRNAs) to edit multiple targets at the single-nucleotide level simultaneously.48
Table 1. Resolution of Multiplex Genome Editing in Microorganisms Using Cas Nuclease or Nickasea.
| resolution (nt) | no. of targets | efficiency (%) | species | type of Cas nuclease | how to express gRNAs in plasmid | donor template DNA | description | ref |
|---|---|---|---|---|---|---|---|---|
| 1 | 3 | 13.3 | Saccharomyces cerevisiae | Cas9-NG | polycistronic sgRNA array | plasmid | single-nucleotide editing using gRNA-tRNA array and Cas9-NG | (49) |
| 1 | 3 | 9 | Escherichia coli | Cas9 | separate sgRNA cassettes | ssOligo | single-nucleotide editing using 5′-end-truncated sgRNAs | (48) |
| 1 | 3 | 3.7 | Corynebacterium glutamicum | Cas12a | polycistronic crRNA array | ssOligo | CRISPR-Cas12a-RecT system | (47) |
| 1 | 2 | 25 | S. cerevisiae | Cas9 | Separate sgRNA cassettes | dsOligo | simultaneous gene deletion, integration, and point mutation | (50) |
| 2 | 2 | 88 | E. coli | Cas9 | separate sgRNA cassettes | ssOligo | overexpression of RecX to inhibit RecA | (88) |
| 2 | 2 | 70 | E. coli | Cas9 | tandem monocistronic sgRNA array | ssOligo | overexpression of RecX to inhibit RecA | (87) |
| 2 | 2 | 60 | E. coli | Cas12a | polycistronic crRNA array | ssOligo | CRISPR-Cas12a-based double-plasmid system | (91) |
| 3 | 6 | n/d | Bacillus subtilis | Cas12a | polycistronic crRNA array | PCR product | overexpression of protein that promotes HDR and post-transformation incubation | (52) |
| 3 | 5 | 100 | S. cerevisiae | Cas9 | tandem monocistronic sgRNA array | dsOligo | efficient construction of multiple gRNA vectors by the USER-cloning method | (151) |
| 3 | 3 | 23 | E. coli | Cas9 | polycistronic sgRNA array | ssOligo | λ-red and ssOligo-mediated metabolic engineering | (152) |
| 3 | 2 | 40 | C. glutamicum | Cas9 | tandem monocistronic sgRNA array | ssOligo | two-plasmid-based CRISPR-Cas9 system and a simplified cotransformation method | (153) |
| 4 | 3 | 65 | B. subtilis | Cas9n | tandem monocistronic sgRNA array | plasmid | enhancing HDR efficiency by ligD knockout | (58) |
| 4 | 2 | 4 | Komagataella phaffii | Cas9 | polycistronic sgRNA array | PCR product | screening for gene knockouts by gel electrophoresis | (154) |
Note: n/d, not determined; ssOligo, single-stranded oligonucleotide; dsOligo, double-stranded oligonucleotide; HDR, homology-directed repair; Cas9n, Cas9 nickase.
During multiplex editing using Cas nucleases, the cell cannot survive due to DSB if one target in the genome remains unedited. Therefore, as the number of targets increases, the survival rate and editing efficiency of the cells inevitably decrease. To the best of our knowledge, the maximum number of targets that have been simultaneously edited using Cas nuclease was reported in Bacillus subtilis, where stop codons were introduced into six genes.52 In E. coli, simultaneous deletions of 500 bp at four distinct genetic loci have been achieved with an efficiency of 40%.53 In yeast, the highest number of targets simultaneously edited stands at eight, accomplished through transfer RNA (tRNA)-mediated gRNA processing.54 Due to high homologous recombination efficiency in yeast, it is common to use a method that separately introduces a plasmid backbone and multiple gRNA fragments into the cell, enabling the in vivo assembly of a gRNA plasmid for multiplex editing.50,55,56
Although not commonly used, the application of Cas nickase, which induces only single-strand breaks (SSBs), can enhance the cellular repair process, thereby improving the likelihood of obtaining successfully edited cells.57−59 In B. subtilis, the efficiency of simultaneous editing at three targets was 19.5% with Cas9 and 49.0% with Cas9 nickase, with the latter also resulting in a higher cell survival rate.58
4. Multiplex Microbial Genome Editing by Base Editor
Base editors, unlike Cas nucleases, do not require donor template DNA and can recognize multiple genomic targets to simultaneously create mutations within the editing window. This technology is widely applicable to multiplex genome editing in various bacterial species (Table 2). To date, the highest number of target genes simultaneously edited was 17 in Streptomyces coelicolor, where a plasmid containing 28 sgRNAs was introduced into the cell through conjugation.60 The number of simultaneously edited targets varied among the edited colonies, with counts of 17, 10, and 9 targets. This variability was due to intermolecular recombination occurring between repeating sgRNA sequences, leading to a different number of sgRNAs in the plasmid within each colony. In E. coli, dCas9-cytosine deaminase (CDA) construct failed to obtain multiplex-edited cells.61 However, by attaching the ugi gene encoding uracil glycosylase inhibitor, the mutagenesis rate in the multiple sites was increased. Consequently, it was possible to simultaneously edit six genes with an efficiency of 87.5%. In Bacillus subtilis, when only weak promoter was employed for the expression of base editors, three to five target genes can be simultaneously edited.62
Table 2. Efficiency of Multiplex Genome Editing in Microorganisms Using Base Editora.
| no. of targets | efficiency (%) | species | type of base editor | how to express gRNAs in plasmid | description | ref |
|---|---|---|---|---|---|---|
| 17 | n/d | Streptomyces coelicolor | CBE | polycistronic sgRNA array | Csy4-based sgRNA processing and stronger promoter of sgRNA array | (60) |
| 6 | 87.5 | E. coli | CBE | tandem monocistronic sgRNA array | use of a uracil DNA glycosylase inhibitor and a degradation tag | (61) |
| 5 | 75 | B. subtilis | CBE | polycistronic sgRNA array | decreasing the expression of the base editor | (62) |
| 5 | 42 | Yarrowia lipolytica | CBE | tandem monocistronic sgRNA array | increasing the expression of the base editor and gRNA copy number, and KU70 deletion | (63) |
| 4 | 50 | Bacteroides thetaiotaomicron | CBE | tandem monocistronic sgRNA array | single-plasmid-based multiplex genome editing | (155) |
| 4 | 30 | Lactococcus lactis | CBE | tandem monocistronic sgRNA array | enhancing editing efficiency by subculturing | (156) |
| 4 | n/d | Xanthomonas oryzae | CBE | polycistronic sgRNA array | CBE promoter optimization | (98) |
| 3 | 100 | E. coli | ABE, CBE | separate one sgRNA cassette and tandem two sgRNA cassettes | laboratory-evolved deaminase | (27) |
| 3 | 45.6 | Shewanella oneidensis | ABE, CBE | tandem monocistronic sgRNA array | post-transformation incubation | (28) |
| 3 | 90 | Sinorhizobium meliloti | ABE | tandem monocistronic sgRNA array | single-plasmid-based multiplex genome editing using the Golden Gate assembly method | (157) |
| 3 | 87.5 | Mycobacterium smegmatis | CBE | tandem monocistronic sgRNA array | StCas9 fusion protein with uracil DNA glycosylase inhibitor or uracil DNA glycosylase | (158) |
| 3 | 35 | Pseudomonas putida | CBE | tandem monocistronic sgRNA array | use of engineered deaminase | (95) |
| 3 | 12.5 | C. glutamicum | CBE | tandem monocistronic sgRNA array | use of engineered deaminase | (159) |
| 3 | 6.7 | Rhodobacter sphaeroides | CBE | tandem monocistronic sgRNA array | second base editor induction by streaking | (160) |
| 2 | 100 | Staphylococcus aureus | ABE | tandem monocistronic sgRNA array | use of engineered deaminase | (96) |
Note: n/d, not determined; CBE, cytosine base editor; ABE, adenine base editor; Csy4, a member of CRISPR-associated endonuclease; StCas9, Cas9 from Streptococcus thermophilus.
In yeast cells, multiplex genome editing is mainly performed by Cas nuclease, and there were not many cases with base editors (Table 2). It has been reported that up to five targets could be edited in a Ku70-deficient strain in Y. lipolytica.63 The efficiency of editing each gene individually exceeded 75%, but it significantly decreased to 16% when attempting to edit five genes simultaneously. By increasing the expression of gRNAs and base editors, the simultaneous editing efficiency was enhanced to 42%.
Although base editors were developed for precise nucleotide substitution, it has a problem with bystander effects.64 The bystander effect refers to cases where a base editor not only alters its specific single target nucleotide but can also unintentionally modify nearby nontarget nucleotides within the editing window. Therefore, it may not always be suitable for precise editing purposes. Base editors can efficiently generate mutant libraries for microbial strain engineering by inducing hypermutation in the target region.65,66
5. Strategies to Improve Multiplex Genome Editing Efficiency
Compared to single-target editing, several issues arise when trying to edit multiple targets simultaneously. In multiple gRNA arrays, the repetitive components frequently lead to problems with the in vitro array synthesis and in vivo stable expression.67 The level of Cas nuclease expression needs to be finely tuned due to the decreased cell survival ratio caused by DSBs occurring in multiple loci in the genome.68 The efficiency of donor template DNA introduction into cells should be increased when Cas nuclease is used. There have been attempts to address these issues to enhance the efficiency of multiplex genome editing. Successful strategies are examined in detail in the following sections.
5.1. Multiple gRNA Expression Methods
The stable expression of multiple gRNAs is one of the most crucial elements for efficient multiplex genome editing. It is more efficient to express multiple gRNAs on a single plasmid than to transform multiple gRNA plasmids recognizing different targets.46 Various methods for producing multiple gRNA plasmids are introduced as follows. First, a method of separately expressing trans-activating CRISPR RNA (tracrRNA) and a crRNA array was employed similar to the natural CRISPR-Cas system, to prevent the loss of gRNA caused by recombination events between identical sequences repeated within each gRNA scaffold (Figure 4A).32
Figure 4.
Various arrays of target-recognizing gRNAs in plasmid constructs. (A) tracrRNA and crRNA array, like the original CRISPR-Cas system.32 (B) Polycistronic gRNA array flanking tRNA,54 HH/HDV ribozymes,82 or Csy4 site60 for in vivo RNA transcript processing. (C) Tandem monocistronic gRNA array carrying each promoter and terminator.72 (D) Separated monocistronic gRNAs between ori and antibiotic resistance markers.48
Second, to facilitate efficient gRNA processing from a polycistronic transcript, elements such as Csy4 or tRNAs can be inserted between gRNAs. Csy4 recognizes and cleaves at the Csy4 site.69 RNases P and Z can target 5′-leader and 3′-trailer sequences of tRNAs, respectively.70 In addition, ribozyme moieties such as hammerhead (HH) or hepatitis delta virus (HDV) can be also inserted (Figure 4B).33 Self-cleaving HH or HDV ribozymes act on the intramolecular cleavage site.71 Third, a tandem monocistronic gRNA array in a multiple gRNA plasmid can be conveniently created through the Golden Gate assembly or Gibson assembly method for the desired transcript levels of gRNAs (Figure 4C).72 This method can address the issue of transcriptional polarity, where downstream gRNAs in a long transcript may be expressed at lower levels.73
Repeated promoter and terminator sequences may lead to the loss of gRNAs in the multiple gRNA plasmid due to homologous recombination.74 Furthermore, the loss of gRNA caused by homologous recombination between repeated sequences in the gRNA array resulted in colonies edited only on a few of the multiple targets, reducing multiplex editing efficiency.60,75−77 A method to increase the heterogeneity within a polycistronic gRNA array by modifying the gRNA scaffold itself and using different tRNAs for processing has been proposed, but there are still many repeated sequences between each gRNA.78 Recently, gRNA cassettes were placed in the plasmid between the origin of replication (ori) and antibiotic markers in a plasmid to prevent the loss of gRNAs (Figure 4D).48
Next, to increase the copy number of multiple gRNAs within a cell, strong promoters are sometimes used,45,79 and high-copy-number plasmids are also used.80 Because the use of strong promoters can impose a growth burden, the utilization of a weaker promoter may be necessary.81 Therefore, it seems crucial to optimize the appropriate amount of gRNAs based on the microbial species and the number of targets by experimenting with plasmids of varying copy numbers or gRNA promoters of different strengths.
5.2. Regulation of DNA Repair and Recombination
DSBs induced by Cas nucleases at target sites are typically repaired through the NHEJ mechanism. This process often results in random indel mutations that can lead to the inactivation of the target gene.18 For precise editing of the target sequence, introducing donor template DNA into the cell allows for detailed editing via homologous recombination at the DSB site.19
Although suppression of the NHEJ pathway can affect normal cell growth,83 genes involved in the NHEJ mechanism, such as ligD, ku70, and ku80, can be knocked out to enhance the efficiency of homologous recombination in multiplex genome editing.58,84,85 There was an instance where the E. coli RecA protein was overexpressed to boost homologous recombination efficiency during CRISPR-Cas9-mediated multiplex pathway engineering.86 Conversely, there were reports that overexpression of RecX, which inhibits RecA activity, can effectively improve the efficiency of CRISPR-Cas9-optimized multiplex genome editing.87,88
To increase homologous recombination of the donor template DNA, phage-derived recombinase can be overexpressed. In addition to the widely used λ-red protein89 or RecET derived from Rac prophage,90 efforts are underway to identify new recombinases that can further increase editing efficiency.91,92 Additionally, there have been reports that overexpression of proteins, such as mutated NgAgo (Natronobacterium gregoryi Argonaute protein without enzyme activity),52 AtpD (β-subunit of ATP synthase),93 and hBrex27 (exon 27 domain of human BRCA2)94 can increase the efficiency of homologous recombination, thereby improving the efficiency of multiplex genome editing.
5.3. Use of Engineered Editing Tools and Optimization of Recovery Conditions
A Cas9 nuclease variant obtained during its cloning process could be used to enhance the efficiency of multiplex editing.80,82 Using a deaminase unit (e.g., APOBEC1, CDA1, TadA) obtained through protein engineering, higher editing efficiency could be achieved in multiplex editing.27,95,96 The application of AI-based structure prediction and protein engineering technologies to obtain and screen Cas nuclease and deaminase variants appears to have a positive impact on the multiplex genome editing field.97
Regulating the expression of Cas nuclease, Cas nickase, or the base editor is crucial to minimize their impact on cellular function. The most common approach is to optimize promoter strength62,98 There is also a method for direct control of Cas9 activity by expressing anti-CRISPR proteins.93 AcrII4 (anti-CRISPR protein) could prevent leaky expression of Cas9 during delivery of the Cas9 editing tools into S. coelicolor, increasing the survival rate of S. coelicolor cells and facilitating efficient multiplex genome editing.
Recovery conditions, such as duration and subculture, also seem to affect editing efficiency. Extending the post-transformation incubation period can improve editing efficiency.28,52,99 Additionally, subculturing of editing candidates is a common and effective strategy.59,100,101 Particularly when using Cas nickase, partial editing can lead to a mixed-genotype where only a few of the multiple targets are edited even if any sgRNA is not lost. However, cells with completely edited multiple targets could be obtained through the subculture process.59 Nonetheless, during the subculture process, spontaneous mutations and adaptive mutations can occur,102,103 potentially compromising the accuracy of the editing.
5.4. Other Strategies
As the number of targets increases, multiple copies of gRNAs compete for binding with the limited quantity of Cas protein expressed within the cell.67 If the expression of the Cas protein, which has a high affinity for nucleic acids, is increased unnecessarily, it will inevitably burden the cell.104 Therefore, in multiplex genome editing, the endogenous CRISPR-Cas system could be used to alleviate the toxicity of heterologous Cas proteins.101,105−108 Other types of CRISPR-Cas systems, such as Cas12a (also known as Cpf1, 1200–1500 amino acids109) could be used in organisms like Corynebacterium glutamicum and cyanobacteria, where editing is challenging due to the toxicity of Cas9 (900–1700 aa110).111 Furthermore, the easily deliverable miniature Cas12f (400–700 aa112) and Cas12j (700–800 aa113) could also be used for multiplex genome editing.
For successful high-efficiency simultaneous editing of multiple targets, a deep molecular-level understanding of nucleic acid metabolism, such as DNA structure, repair, and recombination mechanisms, will be required. Among multiple targets, some may not be edited effectively, and three-dimensional (3D) genome topology data could also be helpful in selecting editing target loci and improving editing efficiency.
6. Application of Multiplex Microbial Genome Editing
When selecting microbial strains for multiplex genome editing, there are typically two approaches. The first approach involves choosing strains that have robust genome editing capabilities, making them suitable for integrating foreign genes.114 The second approach focuses on selecting strains that already exhibit the desired traits; these strains are then enhanced or upgraded using genome editing, but without introducing any foreign genes. In both scenarios, genome editing tools are essential for strain engineering. After the genome editing process, it is important to ensure that the editing tools are not left behind, as their presence could cause environmental or ecosystem issues.115
Techniques such as the use of counter-selectable markers and temperature-sensitive ori of plasmids allow for scarless editing that is indistinguishable from natural or chemical mutagenesis.116,117 Efficient use of genome editing tools in microorganisms and ensuring their removal post-editing will significantly advance the development of agriculture and the food industry. The following discussion will explore how CRISPR-Cas technology can be applied in the area of agricultural biologicals, strain engineering for microbial production, and improvement of probiotic strains, as well as the potential evolution of each field through multiplex genome editing technology.
6.1. Agricultural Microorganisms
Efforts are ongoing to reduce the use of synthetic pesticides and chemical fertilizers for eco-friendly agriculture and sustainable production, but for high productivity, it is not easy to prohibit the use of environmentally harmful chemicals. The performance of currently used biopesticides still needs to be improved. Bacillus thuringiensis, a representative biopesticide, plays dual roles in agriculture. Its spores contain an insecticidal crystal protein that eradicates pests feeding on crops, and the bacterium can enzymatically degrade the quorum sensing signals of plant pathogens, thereby protecting plants from bacterial infections.118 When B. thuringiensis is utilized on a large scale in agriculture, its crystal protein is vulnerable to degradation by ultraviolet rays. To mitigate this weakness, strains have been developed through genome editing using the CRISPR-Cas9 system that can produce melanin, enhancing their UV resistance.119
Biofertilizers are bacteria or fungi that can facilitate nitrogen fixation, plant growth hormone secretion, and promote plant nutrient absorption.120 If functional microbial strains that produce substances helpful for plant growth, such as auxin or naringenin, are created and used, from which a synergistic effect can be obtained.121 Genome editing tools have been developed in some rhizospheric bacteria, such as Bacillus mycoides and B. subtilis.122 Therefore, further research could be carried out to improve the performance of these strains. There have been few instances where multiplex genome editing has been applied to agricultural biologicals such as biopesticides or biofertilizers. However, it is anticipated that this technology will soon be widely utilized to develop strains with multiple functions and enhanced performance.
6.2. Cell Factories
The use of microorganisms as cell factories for the production of valuable substances will continue to increase.123 Considering the handling of toxic substances produced by chemical synthesis and the cost of refining byproducts, the production of food additives, nutrients, and antibiotics through microbial cell factories is much more eco-friendly. Typically, wild-type strains are not highly productive, but their productivity can be increased by expressing heterologous genes or modifying metabolic pathways. Currently, multiplex genome editing technology is primarily utilized to stably express heterologous genes by integrating them into the genome (Table 3). Antioxidants such as astaxanthin124,125 and β-carotene,126,127 which can be used as food additives, are being produced in S. cerevisiae through heterologous gene expression.
Table 3. Biochemical Production in Engineered Strains via Multiplex CRISPR-Cas Genome Editinga.
| target product | type of metabolic pathway modification | species (no. of multiplex-edited targets) | production level | ref |
|---|---|---|---|---|
| Base Editor-Mediated Strain Engineering | ||||
| glutamate | gene knockout | C. glutamicum (3) | 4.3 g/L (3-fold increase) | (100) |
| naringenin | gene knockout | Y. lipolytica (4) | 120 mg/L (2-fold increase) | (63) |
| protocatechuic acid | gene knockout | P. putida (9) | 2.1 g/L | (161) |
| gene knockout | P. putida (2) | 264.9 mg/L (611.17% increase) | (95) | |
| riboflavin | RBS optimization | S. oneidensis (3) | 3-fold increase | (28) |
| Cas Nuclease-Mediated Strain Engineering | ||||
| N-acetylglucosamine | gene knockout | B. subtilis (6) | 2.2 g/L (1.51-fold increase) | (52) |
| astaxanthin | integration of heterologous genes | K. phaffii (3) | n/d | (124) |
| integration of heterologous genes | S. cerevisiae (3–5) | n/d | (125) | |
| β-carotene | RBS optimization | E. coli (3) | 212 mg/L (2.8-fold increase) | (152) |
| integration of heterologous genes | S. cerevisiae (3) | n/d | (126) | |
| integration of heterologous genes | S. cerevisiae (3) | 12.7 mg/L | (127) | |
| p-coumaric acid | integration of feedback-resistant genes | S. cerevisiae (2) | 4-fold increase | (162) |
| free fatty acids | gene knockout | S. cerevisiae (4) | 559.52 mg/L (30-fold increase) | (54) |
| 3-hydroxypropionic acid | integration of heterologous genes | S. cerevisiae (3) | 195% increase | (163) |
| lactate | integration of heterologous genes | S. cerevisiae (4) | 1.7 g/L | (79) |
| 3-methylcatechol | integration of heterologous genes | K. phaffii (2–3) | n/d | (164) |
| 6-methylsalicylic acid | integration of heterologous genes | K. phaffii (2–3) | n/d | (164) |
| mevalonate | gene knockout | S. cerevisiae (5) | 1.5 mg/L (41.5-fold increase) | (151) |
| mogrol | integration of heterologous genes | S. cerevisiae (4) | 5.9 mg/L | (94) |
| patchoulol | integration and optimization of heterologous genes | S. cerevisiae (3) | 52 mg/L | (165) |
| protocatechuic acid | integration of heterologous genes | S. cerevisiae (3) | 2.7 g/L | (84) |
| integration of heterologous genes | Kluyveromyces lactis (3) | 1.9 g/L | (84) | |
| resveratrol | integration of heterologous genes | Ogataea polymorpha (3) | 4.7 mg/L | (166) |
| riboflavin | RBS optimization | B. subtilis (3) | 1.4 g/L (159% increase) | (58) |
Note: RBS, ribosome binding site; n/d, not determined.
If the pathway for the target metabolite is known, the yield can be increased by modifying the RBS or knocking out the genes involved in the formation of byproducts. In the case of RBS modification, changing even a single nucleotide could have a substantial impact on gene expression.128 An RBS library can be created using a base editor. For example, when targeting the RBS regions of genes involved in riboflavin biosynthesis, it was possible to obtain strains with improved riboflavin production among edited strains with various combinations of RBSs.28 Alternatively, the RBS sequences of lycopene biosynthesis genes could be randomly edited by a base editor.129 The advantage of this approach is that only two types of gRNAs are needed to target up to 10 different RBSs.
6.3. Probiotic Strains
In addition to the production of certain substances, bacterial strains could be developed to have specific features according to the purpose (e.g., a strain that expresses less extracellular protease,130 a strain in which five antibiotic biosynthetic gene clusters are knocked out62). For instance, it has recently been reported that two genes can be deleted simultaneously with over 90% efficiency in Lacticaseibacillus paracasei.106 It was possible to confirm the roles of two lactate dehydrogenase genes (ldhD and ldhL) in the stereospecific production of d- and l-forms of lactic acid in L. paracasei. This demonstrates the potential of multiplex genome editing tools to develop lactic acid bacterial strains at the laboratory level. When the editing of real-world probiotic targets becomes feasible, it may then become possible to engineer new strains capable of yielding more beneficial postbiotics.
7. Artificial Intelligence Technology on Genome Editing
AI technology is being utilized to more precisely and efficiently edit targets using CRISPR-Cas technology.131 It is widely used to predict the efficiency of gRNA (Table 4). CRISPR-Cas editing efficiency can be influenced by various factors, notably the genetic sequence and chromatin 3D structure.132,133 Particularly, efforts are also being made to predict genome editing efficiency by integrating 3D genomics research data.134 Prokaryotic chromatin structures undergo dynamic changes due to processes such as cell division and gene expression.135 gRNA design tools trained with eukaryotic organism data do not accurately predict efficiency when applied to bacteria.136 Therefore, tools have been developed for designing gRNAs for bacteria.136−139
Table 4. AI-Based gRNA Efficiency Prediction Tools for Microorganismsa.
| name of tool | species | type of Cas nuclease | description | ref |
|---|---|---|---|---|
| sgRNA-cleavage-activity-prediction | E. coli | SpCas9, eSpCas9 | consideration of GG dimers and GC content | (136) |
| DeepSgRNABacteria | E. coli | SpCas9, eSpCas9 | training on the differences between prokaryotes and eukaryotes | (137) |
| ssCRISPR | E. coli, Pseudomonas spp. | SpCas9, LbCas12a | design of strain-specific gRNA based on genome information | (138) |
| crisprHAL | Citrobacter rodentium, E. coli, Salmonella enterica | SpCas9, TevSpCas9 | gRNA prediction by excluding gRNAs that hinder cell growth | (139) |
| DeepGuide | Y. lipolytica | SpCas9, LbCas12a | training of strain-specific in vivo cleavage profile and nucleosome occupancy data | (167) |
| crispRdesignR | S. cerevisiae | SpCas9 | consideration of hairpin structure, GC content, and homopolymer (e.g., GGGG, TTTT) | (168) |
Note: SpCas9, Cas9 from Streptococcus pyogenes; LbCas12a, Cas12a from Lachnospiraceae bacterium ND2006; eSpCas9, An engineerd SpCas9 variant with high-fidelity (K848A/K1003A/R1060A);169 TevSpCas9, I-TevI nuclease domain–SpCas9 fusion protein;170 All source codes are available on https://github.com/.
When optimally designed gRNAs for Cas nuclease are used in base editor-mediated editing, the editing efficiency is often not high. Notably, specific bacterial design tools for base editors and prime editors have not yet been developed. A gRNA efficiency prediction tool suitable for base editors has been developed, allowing for the prediction of base-editing efficiency and outcome product frequencies in the human genome.140 For prime editors, a machine learning-based model has been developed to predict the editing efficiency of gRNA by considering factors such as the total length of the primer-binding site and editing template in pegRNA, as well as the GC ratio.141
AI-based protein structure engineering can also be used to enhance CRISPR editing tools to improve editing efficiency. Through the combination of a multidomain mutation library and the utilization of machine learning, the identified optimal Cas9 variant demonstrated a 7.5-fold increase in editing activity compared to the wild-type Cas9 nuclease.142 In another study, by calculating the expected editing efficiency from combining Cas9 variants with deaminase variants, it was possible to obtain an enhanced base editor with up to a 20-fold efficiency improvement.143
AI technology is being used in the field of metabolic pathway engineering to increase the production of valuable substances.144 Novel biosynthetic gene clusters in microbial genomes could be predicted,145 and the process of designing and evaluating synthetic promoters could be facilitated by AI-based methods.146,147 A deep learning-derived RBS–phenotype prediction model enabled the screening of only 3% of the RBS library, reducing experimental efforts while enhancing limonene productivity in E. coli.148 A machine learning model identified the optimal combination of promoters and terminators for each gene in the heterologous violacein biosynthesis pathway, resulting in a 2.4-fold increase in productivity in S. cerevisiae.149 In addition to fine-tuning the details of biosynthetic pathways to identify the optimal combination, the optimization of metabolic flux analysis is also becoming feasible with AI technologies.150 With the application of multiplex genome editing technologies, these approaches could quickly determine which target genes to select and how to edit their sequences for high yield and productivity in metabolite production.
8. Perspectives
Similar to employing robots and automated systems for the screening of microbial strains with desired characteristics, multiplex CRISPR-Cas genome editing technology offers significant labor and time savings compared to conventional genetic engineering techniques.
The integration of AI technology not only aids the CRISPR-Cas system in predicting optimal genetic targets for desired traits but also contributes to the enhancement of editing efficiency by designing the necessary gRNAs across various CRISPR-Cas editing tools. Furthermore, AI technology will also help overcome the limitations on the number of targets that can be edited at once and significantly reduce the experimental trials and errors when using multiplex genome editing techniques.
The CRISPR technology, with its modularity allowing for distinct recognition and cleavage, will continue to evolve in multiple directions beyond multiplex genome editing. If there are microbes with removable genetic tools and industrial potentials, they can soon be transformed into robust engineered strains using CRISPR-Cas integrative technologies. In the future, multiplex genome editing will become a pivotal technology for the sustainable advancement of the agricultural and food industries.
Acknowledgments
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (2021R1A2C1013606) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI23C0041).
Glossary
Abbreviations
- 3D
three-dimensional
- AI
artificial intelligence
- Cas9
clustered regularly interspaced short palindromic repeats-associated protein 9
- Cas9n
Cas9 nickase
- CRISPR
clustered regularly interspaced short palindromic repeats
- crRNA
CRISPR RNA
- DSB
double-strand break
- gRNA
guide RNA
- HDR
homology-directed repair
- NHEJ
non-homologous end joining
- PAM
protospacer-adjacent motif
- pegRNA
prime editing guide RNA
- RBS
ribosome binding site
- sgRNA
single-guide RNA
- SSB
single-strand break
- tracrRNA
trans-activating CRISPR RNA
- tRNA
transfer RNA
- TRS
target recognition sequence
The authors declare no competing financial interest.
References
- Yıldırım K.; Miladinović D.; Sweet J.; Akin M.; Galović V.; Kavas M.; Zlatković M.; de Andrade E. Genome editing for healthy crops: traits, tools and impacts. Front. Plant Sci. 2023, 14, 1231013. 10.3389/fpls.2023.1231013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leitão A. L.; Costa M. C.; Enguita F. J. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites. J. Biotechnol. 2017, 241, 50–60. 10.1016/j.jbiotec.2016.11.009. [DOI] [PubMed] [Google Scholar]
- Lee H.; Yoon D. E.; Kim K. Genome editing methods in animal models. Anim. Cells Syst. 2020, 24, 8–16. 10.1080/19768354.2020.1726462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li H.; Yang Y.; Hong W.; Huang M.; Wu M.; Zhao X. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct. Target. Ther. 2020, 5, 1. 10.1038/s41392-019-0089-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jinek M.; Chylinski K.; Fonfara I.; Hauer M.; Doudna J. A.; Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337, 816–821. 10.1126/science.1225829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gupta R. M.; Musunuru K. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J. Clin. Invest. 2014, 124, 4154–4161. 10.1172/JCI72992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selle K.; Barrangou R. Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol. 2015, 23, 225–232. 10.1016/j.tim.2015.01.008. [DOI] [PubMed] [Google Scholar]
- Stovicek V.; Holkenbrink C.; Borodina I. CRISPR/Cas system for yeast genome engineering: advances and applications. FEMS Yeast Res. 2017, 17, fox030. 10.1093/femsyr/fox030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ullah M.; Xia L.; Xie S.; Sun S. CRISPR/Cas9-based genome engineering: A new breakthrough in the genetic manipulation of filamentous fungi. Biotechnol. Appl. Biochem. 2020, 67, 835–851. 10.1002/bab.2077. [DOI] [PubMed] [Google Scholar]
- Zhu H.; Li C.; Gao C. Applications of CRISPR-Cas in agriculture and plant biotechnology. Nat. Rev. Mol. Cell Biol. 2020, 21, 661–677. 10.1038/s41580-020-00288-9. [DOI] [PubMed] [Google Scholar]
- Sun D.; Guo Z.; Liu Y.; Zhang Y. Progress and prospects of CRISPR/Cas systems in insects and other arthropods. Front. Physiol. 2017, 8, 608. 10.3389/fphys.2017.00608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin Y.; Li J.; Li C.; Tu Z.; Li S.; Li X.-J.; Yan S. Application of CRISPR/Cas9 system in establishing large animal models. Front. Cell Dev. Biol. 2022, 10, 919155. 10.3389/fcell.2022.919155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu Y.; Li Z. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput. Struct. Biotechnol. J. 2020, 18, 2401–2415. 10.1016/j.csbj.2020.08.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herrgård M.; Panagiotou G. Analyzing the genomic variation of microbial cell factories in the era of “New Biotechnology. Comput. Struct. Biotechnol. J. 2012, 3, e201210012 10.5936/csbj.201210012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bailey J. E.; Sburlati A.; Hatzimanikatis V.; Lee K.; Renner W. A.; Tsai P. S. Inverse metabolic engineering: A strategy for directed genetic engineering of useful phenotypes. Biotechnol. Bioeng. 1996, 52, 109–121. . [DOI] [PubMed] [Google Scholar]
- Lee D.-H.; Feist A. M.; Barrett C. L.; Palsson B. Ø. Cumulative number of cell divisions as a meaningful timescale for adaptive laboratory evolution of Escherichia coli. PLoS One 2011, 6, e26172 10.1371/journal.pone.0026172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim H. J.; Jeong H.; Hwang S.; Lee M.-S.; Lee Y.-J.; Lee D.-W.; Lee S. J. Short-term differential adaptation to anaerobic stress via genomic mutations by Escherichia coli strains K-12 and B lacking alcohol dehydrogenase. Front. Microbiol. 2014, 5, 102720. 10.3389/fmicb.2014.00476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang H. H.; Pannunzio N. R.; Adachi N.; Lieber M. R. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 2017, 18, 495–506. 10.1038/nrm.2017.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsu P. D.; Lander E. S.; Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157, 1262–1278. 10.1016/j.cell.2014.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Komor A. C.; Kim Y. B.; Packer M. S.; Zuris J. A.; Liu D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 2016, 533, 420–424. 10.1038/nature17946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaudelli N. M.; Komor A. C.; Rees H. A.; Packer M. S.; Badran A. H.; Bryson D. I.; Liu D. R. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 2017, 551, 464–471. 10.1038/nature24644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Porto E. M.; Komor A. C. In the business of base editors: evolution from bench to bedside. PLoS Biol. 2023, 21, e3002071 10.1371/journal.pbio.3002071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Komor A. C.; Zhao K. T.; Packer M. S.; Gaudelli N. M.; Waterbury A. L.; Koblan L. W.; Kim Y. B.; Badran A. H.; Liu D. R. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci. Adv. 2017, 3, eaao4774 10.1126/sciadv.aao4774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim Y. B.; Komor A. C.; Levy J. M.; Packer M. S.; Zhao K. T.; Liu D. R. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat. Biotechnol. 2017, 35, 371–376. 10.1038/nbt.3803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Richter M. F.; Zhao K. T.; Eton E.; Lapinaite A.; Newby G. A.; Thuronyi B W.; Wilson C.; Koblan L. W.; Zeng J.; Bauer D. E.; Doudna J. A.; Liu D. R. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 2020, 38, 883–891. 10.1038/s41587-020-0453-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hao W.; Cui W.; Suo F.; Han L.; Cheng Z.; Zhou Z. Construction and application of an efficient dual-base editing platform for Bacillus subtilis evolution employing programmable base conversion. Chem. Sci. 2022, 13, 14395–14409. 10.1039/D2SC05824C. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shelake R. M.; Pramanik D.; Kim J.-Y. Improved dual base editor systems (iACBEs) for simultaneous conversion of adenine and cytosine in the bacterium Escherichia coli. mBio 2023, 14, e02296-22 10.1128/mbio.02296-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang T.; Zhang J.; Wei L.; Zhao D.; Bi C.; Liu Q.; Xu N.; Liu J. Developing a PAM-flexible CRISPR-mediated dual-deaminase base editor to regulate extracellular electron transport in Shewanella oneidensis. ACS Synth. Biol. 2023, 12, 1727–1738. 10.1021/acssynbio.3c00045. [DOI] [PubMed] [Google Scholar]
- Li M.; Huo Y.-X.; Guo S. CRISPR-mediated base editing: from precise point mutation to genome-wide engineering in nonmodel microbes. Biology 2022, 11, 571. 10.3390/biology11040571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anzalone A. V.; Randolph P. B.; Davis J. R.; Sousa A. A.; Koblan L. W.; Levy J. M.; Chen P. J.; Wilson C.; Newby G. A.; Raguram A.; Liu D. R. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 2019, 576, 149–157. 10.1038/s41586-019-1711-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang Z.; Liu G. Current advancement in the application of prime editing. Front. Bioeng. Biotechnol. 2023, 11, 1039315. 10.3389/fbioe.2023.1039315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiang W.; Bikard D.; Cox D.; Zhang F.; Marraffini L. A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 2013, 31, 233–239. 10.1038/nbt.2508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ryan O. W; Skerker J. M; Maurer M. J; Li X.; Tsai J. C; Poddar S.; Lee M. E; DeLoache W.; Dueber J. E; Arkin A. P; Cate J. H. Selection of chromosomal DNA libraries using a multiplex CRISPR system. eLife 2014, 3, e03703 10.7554/eLife.03703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adiego-Perez B.; Randazzo P.; Daran J. M.; Verwaal R.; Roubos J. A.; Daran-Lapujade P.; Van Der Oost J. Multiplex genome editing of microorganisms using CRISPR-Cas. FEMS Microbiol. Lett. 2019, 366, fnz086. 10.1093/femsle/fnz086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Utomo J. C.; Hodgins C. L.; Ro D.-K. Multiplex genome editing in yeast by CRISPR/Cas9-a potent and agile tool to reconstruct complex metabolic pathways. Front. Plant Sci. 2021, 12, 719148. 10.3389/fpls.2021.719148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yan F.; Wang J.; Zhang S.; Lu Z.; Li S.; Ji Z.; Song C.; Chen G.; Xu J.; Feng J.; Zhou X.; Zhou H. CRISPR/FnCas12a-mediated efficient multiplex and iterative genome editing in bacterial plant pathogens without donor DNA templates. PLoS Pathog. 2023, 19, e1010961 10.1371/journal.ppat.1010961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finnigan G. C.; Thorner J. mCAL: a new approach for versatile multiplex action of Cas9 using one sgRNA and loci flanked by a programmed target sequence. G3 (Bethesda) 2016, 6, 2147–2156. 10.1534/g3.116.029801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baek S.; Utomo J. C.; Lee J. Y.; Dalal K.; Yoon Y. J.; Ro D.-K. The yeast platform engineered for synthetic gRNA-landing pads enables multiple gene integrations by a single gRNA/Cas9 system. Metab. Eng. 2021, 64, 111–121. 10.1016/j.ymben.2021.01.011. [DOI] [PubMed] [Google Scholar]
- Bourgeois L.; Pyne M. E.; Martin V. J. A highly characterized synthetic landing pad system for precise multicopy gene integration in yeast. ACS Synth. Biol. 2018, 7, 2675–2685. 10.1021/acssynbio.8b00339. [DOI] [PubMed] [Google Scholar]
- Ferreira R.; Gatto F.; Nielsen J. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes. FEBS Lett. 2017, 591, 3288–3295. 10.1002/1873-3468.12835. [DOI] [PubMed] [Google Scholar]
- Kruasuwan W.; Puseenam A.; Tanapongpipat S.; Roongsawang N. Multiplexed CRISPR-mediated engineering of protein secretory pathway genes in the thermotolerant methylotrophic yeast Ogataea thermomethanolica. PLoS One 2021, 16, e0261754 10.1371/journal.pone.0261754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Juergens H.; Varela J. A; Gorter de Vries A. R; Perli T.; Gast V. J M; Gyurchev N. Y; Rajkumar A. S; Mans R.; Pronk J. T; Morrissey J. P; Daran J.-M. G Genome editing in Kluyveromyces and Ogataea yeasts using a broad-host-range Cas9/gRNA co-expression plasmid. FEMS Yeast Res. 2018, 18, foy012. 10.1093/femsyr/foy012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weninger A.; Hatzl A.-M.; Schmid C.; Vogl T.; Glieder A. Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris. J. Biotechnol. 2016, 235, 139–149. 10.1016/j.jbiotec.2016.03.027. [DOI] [PubMed] [Google Scholar]
- Cao M.; Gao M.; Ploessl D.; Song C.; Shao Z. CRISPR-mediated genome editing and gene repression in Scheffersomyces stipitis. Biotechnol. J. 2018, 13, 1700598. 10.1002/biot.201700598. [DOI] [PubMed] [Google Scholar]
- Yang Z.; Edwards H.; Xu P. CRISPR-Cas12a/Cpf1-assisted precise, efficient and multiplexed genome-editing in Yarrowia lipolytica. Metab. Eng. Commun. 2020, 10, e00112 10.1016/j.mec.2019.e00112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao S.; Tong Y.; Wen Z.; Zhu L.; Ge M.; Chen D.; Jiang Y.; Yang S. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system. J. Ind. Microbiol. Biotechnol. 2016, 43, 1085–1093. 10.1007/s10295-016-1789-8. [DOI] [PubMed] [Google Scholar]
- Zhao N.; Li L.; Luo G.; Xie S.; Lin Y.; Han S.; Huang Y.; Zheng S. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum. J. Ind. Microbiol. Biotechnol. 2020, 47, 599–608. 10.1007/s10295-020-02304-5. [DOI] [PubMed] [Google Scholar]
- Lim S. R.; Lee H. J.; Kim H. J.; Lee S. J. Multiplex single-nucleotide microbial genome editing achieved by CRISPR-Cas9 using 5′-end-truncated sgRNAs. ACS Synth. Biol. 2023, 12, 2203–2207. 10.1021/acssynbio.3c00323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gong G.; Zhang Y.; Wang Z.; Liu L.; Shi S.; Siewers V.; Yuan Q.; Nielsen J.; Zhang X.; Liu Z. GTR 2.0: gRNA-tRNA array and Cas9-NG based genome disruption and single-nucleotide conversion in Saccharomyces cerevisiae. ACS Synth. Biol. 2021, 10, 1328–1337. 10.1021/acssynbio.0c00560. [DOI] [PubMed] [Google Scholar]
- Mans R.; van Rossum H. M.; Wijsman M.; Backx A.; Kuijpers N. G.; van den Broek M.; Daran-Lapujade P.; Pronk J. T.; van Maris A. J.; Daran J.-M. G. CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae. FEMS Yeast Res. 2015, 15, fov004. 10.1093/femsyr/fov004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee H. J.; Kim H. J.; Lee S. J. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs. Genome Res. 2020, 30, 768–775. 10.1101/gr.257493.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu Y.; Liu Y.; Lv X.; Li J.; Du G.; Liu L. CAMERS-B: CRISPR/Cpf1 assisted multiple-genes editing and regulation system for Bacillus subtilis. Biotechnol. Bioeng. 2020, 117, 1817–1825. 10.1002/bit.27322. [DOI] [PubMed] [Google Scholar]
- Feng X.; Zhao D.; Zhang X.; Ding X.; Bi C. CRISPR/Cas9 assisted multiplex genome editing technique in Escherichia coli. Biotechnol. J. 2018, 13, 1700604. 10.1002/biot.201700604. [DOI] [PubMed] [Google Scholar]
- Zhang Y.; Wang J.; Wang Z.; Zhang Y.; Shi S.; Nielsen J.; Liu Z. A gRNA-tRNA array for CRISPR-Cas9 based rapid multiplexed genome editing in Saccharomyces cerevisiae. Nat. Commun. 2019, 10, 1053. 10.1038/s41467-019-09005-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Degreif D.; Kremenovic M.; Geiger T.; Bertl A. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing. J. Biol. Methods 2018, 5, e98 10.14440/jbm.2018.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jacobus A. P.; Barreto J. A.; De Bem L. S.; Menegon Y. A.; Fier C. D.; Bueno J. G.; Dos Santos L. V.; Gross J. EasyGuide plasmids support in vivo assembly of gRNAs for CRISPR/Cas9 applications in Saccharomyces cerevisiae. ACS Synth. Biol. 2022, 11, 3886–3891. 10.1021/acssynbio.2c00348. [DOI] [PubMed] [Google Scholar]
- Li K.; Cai D.; Wang Z.; He Z.; Chen S. Development of an efficient genome editing tool in Bacillus licheniformis using CRISPR-Cas9 nickase. Appl. Environ. Microbiol. 2018, 84, e02608-17 10.1128/AEM.02608-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu D.; Huang C.; Guo J.; Zhang P.; Chen T.; Wang Z.; Zhao X. Development and characterization of a CRISPR/Cas9n-based multiplex genome editing system for Bacillus subtilis. Biotechnol. Biofuels Bioprod. 2019, 12, 197. 10.1186/s13068-019-1537-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ma J.-X.; He W.-Y.; Hua H.-M.; Zhu Q.; Zheng G.-S.; Zimin A. A.; Wang W.-F.; Lu Y.-H. Development of a CRISPR/Cas9D10A nickase (nCas9)-mediated genome editing tool in Streptomyces. ACS Synth. Biol. 2023, 12, 3114–3123. 10.1021/acssynbio.3c00466. [DOI] [PubMed] [Google Scholar]
- Whitford C. M.; Gren T.; Palazzotto E.; Lee S. Y.; Tong Y.; Weber T. Systems analysis of highly multiplexed CRISPR-base editing in Streptomycetes. ACS Synth. Biol. 2023, 12, 2353–2366. 10.1021/acssynbio.3c00188. [DOI] [PubMed] [Google Scholar]
- Banno S.; Nishida K.; Arazoe T.; Mitsunobu H.; Kondo A. Deaminase-mediated multiplex genome editing in Escherichia coli. Nat. Microbiol. 2018, 3, 423–429. 10.1038/s41564-017-0102-6. [DOI] [PubMed] [Google Scholar]
- Kim M. S.; Kim H.-R.; Jeong D.-E.; Choi S.-K. Cytosine base editor-mediated multiplex genome editing to accelerate discovery of novel antibiotics in Bacillus subtilis and Paenibacillus polymyxa. Front. Microbiol. 2021, 12, 691839. 10.3389/fmicb.2021.691839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ganesan V.; Monteiro L.; Pedada D.; Stohr A.; Blenner M. High-efficiency multiplexed cytosine base editors for natural product synthesis in Yarrowia lipolytica. ACS Synth. Biol. 2023, 12, 3082–3091. 10.1021/acssynbio.3c00435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rees H. A.; Liu D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 2018, 19, 770–788. 10.1038/s41576-018-0059-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Y.; Wang R.; Liu J.; Lu H.; Li H.; Wang Y.; Ni X.; Li J.; Guo Y.; Ma H.; Liao X.; Wang M. Base editor enables rational genome-scale functional screening for enhanced industrial phenotypes in Corynebacterium glutamicum. Sci. Adv. 2022, 8, eabq2157 10.1126/sciadv.abq2157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan Y.; Liao X.; Li S.; Xing X.-H.; Zhang C. Base editor-mediated large-scale screening of functional mutations in bacteria for industrial phenotypes. Sci. China Life Sci. 2024, 16, 1051. 10.1007/s11427-023-2468-y. [DOI] [PubMed] [Google Scholar]
- McCarty N. S.; Graham A. E.; Studená L.; Ledesma-Amaro R. Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat. Commun. 2020, 11, 1281. 10.1038/s41467-020-15053-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yao R.; Liu D.; Jia X.; Zheng Y.; Liu W.; Xiao Y. CRISPR-Cas9/Cas12a biotechnology and application in bacteria. Synth. Syst. Biotechnol. 2018, 3, 135–149. 10.1016/j.synbio.2018.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haurwitz R. E.; Jinek M.; Wiedenheft B.; Zhou K.; Doudna J. A. Sequence-and structure-specific RNA processing by a CRISPR endonuclease. Science 2010, 329, 1355–1358. 10.1126/science.1192272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie K.; Minkenberg B.; Yang Y. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc. Natl. Acad. Sci. U.S.A. 2015, 112, 3570–3575. 10.1073/pnas.1420294112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao Y.; Zhao Y. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. J. Integr. Plant Biol. 2014, 56, 343–349. 10.1111/jipb.12152. [DOI] [PubMed] [Google Scholar]
- Cobb R. E.; Wang Y.; Zhao H. High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth. Biol. 2015, 4, 723–728. 10.1021/sb500351f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee H. J.; Jeon H. J.; Ji S. C.; Yun S. H.; Lim H. M. Establishment of an mRNA gradient depends on the promoter: an investigation of polarity in gene expression. J. Mol. Biol. 2008, 378, 318–327. 10.1016/j.jmb.2008.02.067. [DOI] [PubMed] [Google Scholar]
- Prielhofer R.; Barrero J. J.; Steuer S.; Gassler T.; Zahrl R.; Baumann K.; Sauer M.; Mattanovich D.; Gasser B.; Marx H. Golden PiCS: a Golden Gate-derived modular cloning system for applied synthetic biology in the yeast Pichia pastoris. BMC Syst. Biol. 2017, 11, 123. 10.1186/s12918-017-0492-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ao X.; Yao Y.; Li T.; Yang T.-T.; Dong X.; Zheng Z.-T.; Chen G.-Q.; Wu Q.; Guo Y. A multiplex genome editing method for Escherichia coli based on CRISPR-Cas12a. Front. Microbiol. 2018, 9, 2307. 10.3389/fmicb.2018.02307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meliawati M.; Teckentrup C.; Schmid J. CRISPR-Cas9-mediated large cluster deletion and multiplex genome editing in Paenibacillus polymyxa. ACS Synth. Biol. 2022, 11, 77–84. 10.1021/acssynbio.1c00565. [DOI] [PubMed] [Google Scholar]
- Aparicio T.; de Lorenzo V.; Martínez-García E. CRISPR/Cas9-based counterselection boosts recombineering efficiency in Pseudomonas putida. Biotechnol. J. 2018, 13, 1700161. 10.1002/biot.201700161. [DOI] [PubMed] [Google Scholar]
- Wang Y.; Li X.; Liu M.; Zhou Y.; Li F. Guide RNA scaffold variants enabled easy cloning of large gRNA cluster for multiplexed gene editing. Plant Biotechnol. J. 2024, 22, 460–471. 10.1111/pbi.14198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lian J.; Bao Z.; Hu S.; Zhao H. Engineered CRISPR/Cas9 system for multiplex genome engineering of polyploid industrial yeast strains. Biotechnol. Bioeng. 2018, 115, 1630–1635. 10.1002/bit.26569. [DOI] [PubMed] [Google Scholar]
- Bao Z.; Xiao H.; Liang J.; Zhang L.; Xiong X.; Sun N.; Si T.; Zhao H. Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synth. Biol. 2015, 4, 585–594. 10.1021/sb500255k. [DOI] [PubMed] [Google Scholar]
- Hao W.; Suo F.; Lin Q.; Chen Q.; Zhou L.; Liu Z.; Cui W.; Zhou Z. Design and construction of portable CRISPR-Cpf1-mediated genome editing in Bacillus subtilis 168 oriented toward multiple utilities. Front. Bioeng. Biotechnol. 2020, 8, 524676. 10.3389/fbioe.2020.524676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorter de Vries A. R.; de Groot P. A.; van den Broek M.; Daran J.-M. G. CRISPR-Cas9 mediated gene deletions in lager yeast Saccharomyces pastorianus. Microb. Cell Fact. 2017, 16, 222. 10.1186/s12934-017-0835-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Näätsaari L.; Mistlberger B.; Ruth C.; Hajek T.; Hartner F. S.; Glieder A. Deletion of the Pichia pastoris KU70 homologue facilitates platform strain generation for gene expression and synthetic biology. PLoS One 2012, 7, e39720 10.1371/journal.pone.0039720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horwitz A. A.; Walter J. M.; Schubert M. G.; Kung S. H.; Hawkins K.; Platt D. M.; Hernday A. D.; Mahatdejkul-Meadows T.; Szeto W.; Chandran S. S.; Newman J. D. Efficient multiplexed integration of synergistic alleles and metabolic pathways in yeasts via CRISPR-Cas. Cell Syst. 2015, 1, 88–96. 10.1016/j.cels.2015.02.001. [DOI] [PubMed] [Google Scholar]
- Holkenbrink C.; Dam M. I.; Kildegaard K. R.; Beder J.; Dahlin J.; Doménech Belda D.; Borodina I. EasyCloneYALI: CRISPR/Cas9-based synthetic toolbox for engineering of the yeast Yarrowia lipolytica. Biotechnol. J. 2018, 13, 1700543. 10.1002/biot.201700543. [DOI] [PubMed] [Google Scholar]
- Zhu X.; Zhao D.; Qiu H.; Fan F.; Man S.; Bi C.; Zhang X. The CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique and its application to improve the Escherichia coli xylose utilization pathway. Metab. Eng. 2017, 43, 37–45. 10.1016/j.ymben.2017.08.003. [DOI] [PubMed] [Google Scholar]
- Ronda C.; Pedersen L. E.; Sommer M. O.; Nielsen A. T. CRMAGE: CRISPR optimized MAGE recombineering. Sci. Rep. 2016, 6, 19452. 10.1038/srep19452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu H.; Hou G.; Wang P.; Guo G.; Wang Y.; Yang N.; Rehman M. N. U.; Li C.; Li Q.; Zheng J.; Zeng J.; Li S. A double-locus scarless genome editing system in Escherichia coli. Biotechnol. Lett. 2020, 42, 1457–1465. 10.1007/s10529-020-02856-7. [DOI] [PubMed] [Google Scholar]
- Yu D.; Sawitzke J. A.; Ellis H.; Court D. L. Recombineering with overlapping single-stranded DNA oligonucleotides: Testing a recombination intermediate. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 7207–7212. 10.1073/pnas.1232375100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y.; Buchholz F.; Muyrers J. P.; Stewart A. F. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 1998, 20, 123–128. 10.1038/2417. [DOI] [PubMed] [Google Scholar]
- Zhu X.; Wu Y.; Lv X.; Liu Y.; Du G.; Li J.; Liu L. Combining CRISPR-Cpf1 and recombineering facilitates fast and efficient genome editing in Escherichia coli. ACS Synth. Biol. 2022, 11, 1897–1907. 10.1021/acssynbio.2c00041. [DOI] [PubMed] [Google Scholar]
- Liang Y.; Wei Y.; Jiao S.; Yu H. A CRISPR/Cas9-based single-stranded DNA recombineering system for genome editing of Rhodococcus opacus PD630. Synth. Syst. Biotechnol. 2021, 6, 200–208. 10.1016/j.synbio.2021.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiang Y.-H.; Liu Y.-F.; Wang K.; Zhou J.-Y.; Guo F.; Zhao Q.-W.; Mao X.-M. Fine-tuning Cas9 activity with a cognate inhibitor AcrIIA4 to improve genome editing in Streptomyces. ACS Synth. Biol. 2021, 10, 2833–2841. 10.1021/acssynbio.1c00141. [DOI] [PubMed] [Google Scholar]
- Meng J.; Qiu Y.; Zhang Y.; Zhao H.; Shi S. CMI: CRISPR/Cas9 based efficient multiplexed integration in Saccharomyces cerevisiae. ACS Synth. Biol. 2023, 12, 1408–1414. 10.1021/acssynbio.2c00591. [DOI] [PubMed] [Google Scholar]
- Sun J.; Lu L.-B.; Liang T.-X.; Yang L.-R.; Wu J.-P. CRISPR-assisted multiplex base editing system in Pseudomonas putida KT2440. Front. Bioeng. Biotechnol. 2020, 8, 905. 10.3389/fbioe.2020.00905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y.; Zhang H.; Wang Z.; Wu Z.; Wang Y.; Tang N.; Xu X.; Zhao S.; Chen W.; Ji Q. Programmable adenine deamination in bacteria using a Cas9-adenine-deaminase fusion. Chem. Sci. 2020, 11, 1657–1664. 10.1039/C9SC03784E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dixit S.; Kumar A.; Srinivasan K.; Vincent P. D. R.; Ramu Krishnan N. Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions. Front. Bioeng. Biotechnol. 2024, 11, 1335901. 10.3389/fbioe.2023.1335901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li C.; Wang L.; Cseke L. J.; Vasconcelos F.; Huguet-Tapia J. C.; Gassmann W.; Pauwels L.; White F. F.; Dong H.; Yang B. Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria. Commun. Biol. 2023, 6, 56. 10.1038/s42003-023-04451-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abdullah; Wang P.; Han T.; Liu W.; Ren W.; Wu Y.; Xiao Y. Adenine base editing system for Pseudomonas and prediction workflow for protein dysfunction via ABE. ACS Synth. Biol. 2022, 11, 1650–1657. 10.1021/acssynbio.2c00066. [DOI] [PubMed] [Google Scholar]
- Wang Y.; Liu Y.; Liu J.; Guo Y.; Fan L.; Ni X.; Zheng X.; Wang M.; Zheng P.; Sun J.; Ma Y. MACBETH: Multiplex automated Corynebacterium glutamicum base editing method. Metab. Eng. 2018, 47, 200–210. 10.1016/j.ymben.2018.02.016. [DOI] [PubMed] [Google Scholar]
- Zhang J.; Zong W.; Hong W.; Zhang Z.-T.; Wang Y. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production. Metab. Eng. 2018, 47, 49–59. 10.1016/j.ymben.2018.03.007. [DOI] [PubMed] [Google Scholar]
- Williams A. B. Spontaneous mutation rates come into focus in Escherichia coli. DNA repair 2014, 24, 73–79. 10.1016/j.dnarep.2014.09.009. [DOI] [PubMed] [Google Scholar]
- Heo J. M.; Kim H. J.; Lee S. J. Efficient anaerobic consumption of D-xylose by E. coli BL21 (DE3) via xylR adaptive mutation. BMC Microbiol. 2021, 21, 332. 10.1186/s12866-021-02395-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rostain W.; Grebert T.; Vyhovskyi D.; Pizarro P. T.; Tshinsele-Van Bellingen G.; Cui L.; Bikard D. Cas9 off-target binding to the promoter of bacterial genes leads to silencing and toxicity. Nucleic Acids Res. 2023, 51, 3485–3496. 10.1093/nar/gkad170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang Z.; Li Z.; Li B.; Bu R.; Tan G.-Y.; Wang Z.; Yan H.; Xin Z.; Zhang G.; Li M.; Xiang H.; Zhang L.; Wang W. A thermostable type I-B CRISPR-Cas system for orthogonal and multiplexed genetic engineering. Nat. Commun. 2023, 14, 6193. 10.1038/s41467-023-41973-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gu S.; Zhang J.; Li L.; Zhong J. Repurposing the endogenous CRISPR-Cas9 System for high-efficiency genome editing in Lacticaseibacillus paracasei. ACS Synth. Biol. 2022, 11, 4031–4042. 10.1021/acssynbio.2c00374. [DOI] [PubMed] [Google Scholar]
- Zheng Y.; Han J.; Wang B.; Hu X.; Li R.; Shen W.; Ma X.; Ma L.; Yi L.; Yang S.; Peng W. Characterization and repurposing of the endogenous Type I-F CRISPR-Cas system of Zymomonas mobilis for genome engineering. Nucleic Acids Res. 2019, 47, 11461–11475. 10.1093/nar/gkz940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheng F.; Gong L.; Zhao D.; Yang H.; Zhou J.; Li M.; Xiang H. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon. J. Genet. Genom. 2017, 44, 541–548. 10.1016/j.jgg.2017.09.010. [DOI] [PubMed] [Google Scholar]
- Shmakov S.; Abudayyeh O. O.; Makarova K. S.; Wolf Y. I.; Gootenberg J. S.; Semenova E.; Minakhin L.; Joung J.; Konermann S.; Severinov K.; Zhang F.; Koonin E. V. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 2015, 60, 385–397. 10.1016/j.molcel.2015.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chylinski K.; Le Rhun A.; Charpentier E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 2013, 10, 726–737. 10.4161/rna.24321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang Y.; Fu Y. Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing. Cell Biosci. 2018, 8, 59. 10.1186/s13578-018-0255-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harrington L. B.; Burstein D.; Chen J. S.; Paez-Espino D.; Ma E.; Witte I. P.; Cofsky J. C.; Kyrpides N. C.; Banfield J. F.; Doudna J. A. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 2018, 362, 839–842. 10.1126/science.aav4294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pausch P.; Al-Shayeb B.; Bisom-Rapp E.; Tsuchida C. A.; Li Z.; Cress B. F.; Knott G. J.; Jacobsen S. E.; Banfield J. F.; Doudna J. A. CRISPR-CasΦ from huge phages is a hypercompact genome editor. Science 2020, 369, 333–337. 10.1126/science.abb1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim J.; Salvador M.; Saunders E.; Gonzalez J.; Avignone-Rossa C.; Jimenez J. I. Properties of alternative microbial hosts used in synthetic biology: towards the design of a modular chassis. Essays Biochem. 2016, 60, 303–313. 10.1042/EBC20160015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ulanova A.; Mansfeldt C. EcoGenoRisk: Developing a computational ecological risk assessment tool for synthetic biology. Environ. Pollut. 2024, 346, 123647. 10.1016/j.envpol.2024.123647. [DOI] [PubMed] [Google Scholar]
- Reisch C. R.; Prather K. L. The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli. Sci. Rep. 2015, 5, 15096. 10.1038/srep15096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y.; Wang Z.; Chen Y.; Hua X.; Yu Y.; Ji Q. A highly efficient CRISPR-Cas9-based genome engineering platform in Acinetobacter baumannii to understand the H2O2-sensing mechanism of OxyR. Cell Chem. Biol. 2019, 26, 1732–1742.e5. 10.1016/j.chembiol.2019.09.003. [DOI] [PubMed] [Google Scholar]
- Lee S. J.; Park S.-Y.; Lee J.-J.; Yum D.-Y.; Koo B.-T.; Lee J.-K. Genes encoding the N-acyl homoserine lactone-degrading enzyme are widespread in many subspecies of Bacillus thuringiensis. Appl. Environ. Microbiol. 2002, 68, 3919–3924. 10.1128/AEM.68.8.3919-3924.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu L.; Chu Y.; Zhang B.; Yuan X.; Wang K.; Liu Z.; Sun M. Creation of an industrial Bacillus thuringiensis strain with high melanin production and UV tolerance by gene editing. Front. Microbiol. 2022, 13, 913715. 10.3389/fmicb.2022.913715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pirttilä A. M.; Mohammad Parast Tabas H.; Baruah N.; Koskimäki J. J. Biofertilizers and biocontrol agents for agriculture: How to identify and develop new potent microbial strains and traits. Microorganisms 2021, 9, 817. 10.3390/microorganisms9040817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haskett T. L.; Tkacz A.; Poole P. S. Engineering rhizobacteria for sustainable agriculture. ISME J. 2021, 15, 949–964. 10.1038/s41396-020-00835-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yi Y.; Li Z.; Song C.; Kuipers O. P. Exploring plant-microbe interactions of the rhizobacteria Bacillus subtilis and Bacillus mycoides by use of the CRISPR-Cas9 system. Environ. Microbiol. 2018, 20, 4245–4260. 10.1111/1462-2920.14305. [DOI] [PubMed] [Google Scholar]
- Choi K. R.; Lee S. Y. Systems metabolic engineering of microorganisms for food and cosmetics production. Nat. Rev. Bioeng. 2023, 1, 832–857. 10.1038/s44222-023-00076-y. [DOI] [Google Scholar]
- Gao J.; Xu J.; Zuo Y.; Ye C.; Jiang L.; Feng L.; Huang L.; Xu Z.; Lian J. Synthetic biology toolkit for marker-less integration of multigene pathways into Pichia pastoris via CRISPR/Cas9. ACS Synth. Biol. 2022, 11, 623–633. 10.1021/acssynbio.1c00307. [DOI] [PubMed] [Google Scholar]
- Qi M.; Zhang B.; Jiang L.; Xu S.; Dong C.; Du Y.-L.; Zhou Z.; Huang L.; Xu Z.; Lian J. PCR & Go: A pre-installed expression chassis for facile integration of multi-gene biosynthetic pathways. Front. Bioeng. Biotechnol. 2021, 8, 613771. 10.3389/fbioe.2020.613771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malcı K.; Jonguitud-Borrego N.; van der Straten Waillet H.; Puodziunaite U.; Johnston E. J.; Rosser S. J.; Rios-Solis L. ACtivE: Assembly and CRISPR-targeted in vivo editing for yeast genome engineering using minimum reagents and time. ACS Synth. Biol. 2022, 11, 3629–3643. 10.1021/acssynbio.2c00175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ronda C.; Maury J.; Jakočiu̅nas T.; Baallal Jacobsen S. A.; Germann S. M.; Harrison S. J.; Borodina I.; Keasling J. D.; Jensen M. K.; Nielsen A. T. CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae. Microb. Cell Fact. 2015, 14, 97. 10.1186/s12934-015-0288-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen K.; Ke Z.; Wang S.; Wang S.; Yang K.; Jia W.; Zhu J.; Jiang J. Precise regulation of differential transcriptions of various catabolic genes by OdcR via a single nucleotide mutation in the promoter ensures the safety of metabolic flux. Appl. Environ. Microbiol. 2022, 88, e01182-22 10.1128/aem.01182-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y.; Cheng H.; Liu Y.; Liu Y.; Wen X.; Zhang K.; Ni X.; Gao N.; Fan L.; Zhang Z.; Liu J.; Chen J.; Wang L.; Guo Y.; Zheng P.; Wang M.; Sun J.; Ma Y. In-situ generation of large numbers of genetic combinations for metabolic reprogramming via CRISPR-guided base editing. Nat. Commun. 2021, 12, 678. 10.1038/s41467-021-21003-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu S.; Price M. A.; Wang Y.; Liu Y.; Guo Y.; Ni X.; Rosser S. J.; Bi C.; Wang M. CRISPR-dCas9 mediated cytosine deaminase base editing in Bacillus subtilis. ACS Synth. Biol. 2020, 9, 1781–1789. 10.1021/acssynbio.0c00151. [DOI] [PubMed] [Google Scholar]
- Lee M. Deep learning in CRISPR-Cas systems: A review of recent studies. Front. Bioeng. Biotechnol. 2023, 11, 1226182. 10.3389/fbioe.2023.1226182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jensen K. T.; Fløe L.; Petersen T. S.; Huang J.; Xu F.; Bolund L.; Luo Y.; Lin L. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency. FEBS Lett. 2017, 591, 1892–1901. 10.1002/1873-3468.12707. [DOI] [PubMed] [Google Scholar]
- Uusi-Mäkelä M. I.; Barker H. R.; Bäuerlein C. A.; Häkkinen T.; Nykter M.; Rämet M. Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio). PLoS One 2018, 13, e0196238 10.1371/journal.pone.0196238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu Q.; Shou J. Toward precise CRISPR DNA fragment editing and predictable 3D genome engineering. J. Mol. Cell Biol. 2021, 12, 828–856. 10.1093/jmcb/mjaa060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuzminov A. The precarious prokaryotic chromosome. J. Bacteriol. 2014, 196, 1793–1806. 10.1128/JB.00022-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guo J.; Wang T.; Guan C.; Liu B.; Luo C.; Xie Z.; Zhang C.; Xing X.-H. Improved sgRNA design in bacteria via genome-wide activity profiling. Nucleic Acids Res. 2018, 46, 7052–7069. 10.1093/nar/gky572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang L.; Zhang J. Prediction of sgRNA on-target activity in bacteria by deep learning. BMC Bioinform. 2019, 20, 517. 10.1186/s12859-019-3151-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rottinghaus A. G.; Vo S.; Moon T. S. Computational design of CRISPR guide RNAs to enable strain-specific control of microbial consortia. Proc. Natl. Acad. Sci. U.S.A. 2023, 120, e2213154120 10.1073/pnas.2213154120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ham D. T.; Browne T. S.; Banglorewala P. N.; Wilson T. L.; Michael R. K.; Gloor G. B.; Edgell D. R. A generalizable Cas9/sgRNA prediction model using machine transfer learning with small high-quality datasets. Nat. Commun. 2023, 14, 5514. 10.1038/s41467-023-41143-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Song M.; Kim H. K.; Lee S.; Kim Y.; Seo S. Y.; Park J.; Choi J. W.; Jang H.; Shin J. H.; Min S.; et al. Sequence-specific prediction of the efficiencies of adenine and cytosine base editors. Nat. Biotechnol. 2020, 38, 1037–1043. 10.1038/s41587-020-0573-5. [DOI] [PubMed] [Google Scholar]
- Mathis N.; Allam A.; Kissling L.; Marquart K. F.; Schmidheini L.; Solari C.; Balázs Z.; Krauthammer M.; Schwank G. Predicting prime editing efficiency and product purity by deep learning. Nat. Biotechnol. 2023, 41, 1151–1159. 10.1038/s41587-022-01613-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thean D. G. L.; Chu H. Y.; Fong J. H. C.; Chan B. K. C.; Zhou P.; Kwok C. C. S.; Chan Y. M.; Mak S. Y. L.; Choi G. C. G.; Ho J. W. K.; Zheng Z.; Wong A. S. L. Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activities. Nat. Commun. 2022, 13, 2219. 10.1038/s41467-022-29874-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim N.; Choi S.; Kim S.; Song M.; Seo J. H.; Min S.; Park J.; Cho S.-R.; Kim H. H. Deep learning models to predict the editing efficiencies and outcomes of diverse base editors. Nat. Biotechnol. 2024, 42, 484–497. 10.1038/s41587-023-01792-x. [DOI] [PubMed] [Google Scholar]
- Lawson C. E.; Martí J. M.; Radivojevic T.; Jonnalagadda S. V. R.; Gentz R.; Hillson N. J.; Peisert S.; Kim J.; Simmons B. A.; Petzold C. J.; Singer S. W.; Mukhopadhyay A.; Tanjore D.; Dunn J. G.; Garcia Martin H. Machine learning for metabolic engineering: A review. Metab. Eng. 2021, 63, 34–60. 10.1016/j.ymben.2020.10.005. [DOI] [PubMed] [Google Scholar]
- Hannigan G. D; Prihoda D.; Palicka A.; Soukup J.; Klempir O.; Rampula L.; Durcak J.; Wurst M.; Kotowski J.; Chang D.; Wang R.; Piizzi G.; Temesi G.; Hazuda D. J; Woelk C. H; Bitton D. A A deep learning genome-mining strategy for biosynthetic gene cluster prediction. Nucleic Acids Res. 2019, 47, e110 10.1093/nar/gkz654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kotopka B. J.; Smolke C. D. Model-driven generation of artificial yeast promoters. Nat. Commun. 2020, 11, 2113. 10.1038/s41467-020-15977-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin J.; Wang X.; Liu T.; Teng Y.; Cui W.. Diffusion-based generative network for de novo synthetic promoter design. ACS Synth. Biol. 2024, 10.1021/acssynbio.4c00041. [DOI] [PubMed] [Google Scholar]
- Jervis A. J.; Carbonell P.; Vinaixa M.; Dunstan M. S.; Hollywood K. A.; Robinson C. J.; Rattray N. J. W.; Yan C.; Swainston N.; Currin A.; Sung R.; Toogood H.; Taylor S.; Faulon J.-L.; Breitling R.; Takano E.; Scrutton N. S. Machine learning of designed translational control allows predictive pathway optimization in Escherichia coli. ACS Synth. Biol. 2019, 8, 127–136. 10.1021/acssynbio.8b00398. [DOI] [PubMed] [Google Scholar]
- Zhou Y.; Li G.; Dong J.; Xing X.-h.; Dai J.; Zhang C. MiYA, an efficient machine-learning workflow in conjunction with the YeastFab assembly strategy for combinatorial optimization of heterologous metabolic pathways in Saccharomyces cerevisiae. Metab. Eng. 2018, 47, 294–302. 10.1016/j.ymben.2018.03.020. [DOI] [PubMed] [Google Scholar]
- Goshisht M. K. Machine learning and deep learning in synthetic biology: Key architectures, applications, and challenges. ACS Omega 2024, 9, 9921–9945. 10.1021/acsomega.3c05913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jakočiu̅nas T.; Bonde I.; Herrgård M.; Harrison S. J.; Kristensen M.; Pedersen L. E.; Jensen M. K.; Keasling J. D. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab. Eng. 2015, 28, 213–222. 10.1016/j.ymben.2015.01.008. [DOI] [PubMed] [Google Scholar]
- Li Y.; Lin Z.; Huang C.; Zhang Y.; Wang Z.; Tang Y.-j.; Chen T.; Zhao X. Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome editing. Metab. Eng. 2015, 31, 13–21. 10.1016/j.ymben.2015.06.006. [DOI] [PubMed] [Google Scholar]
- Liu J.; Wang Y.; Lu Y.; Zheng P.; Sun J.; Ma Y. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Microb. Cell Fact. 2017, 16, 205. 10.1186/s12934-017-0815-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalvie N. C.; Lorgeree T.; Biedermann A. M.; Love K. R.; Love J. C. Simplified gene knockout by CRISPR-Cas9-induced homologous recombination. ACS Synth. Biol. 2022, 11, 497–501. 10.1021/acssynbio.1c00194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liang J.; Tan Y. Highly efficient CRISPR-mediated base editing for the gut Bacteroides spp. with pnCasBS-CBE. Biotechnol. J. 2023, 18, 2200504. 10.1002/biot.202200504. [DOI] [PubMed] [Google Scholar]
- Tian K.; Hong X.; Guo M.; Li Y.; Wu H.; Caiyin Q.; Qiao J. Development of base editors for simultaneously editing multiple loci in Lactococcus lactis. ACS Synth. Biol. 2022, 11, 3644–3656. 10.1021/acssynbio.1c00561. [DOI] [PubMed] [Google Scholar]
- Wang L.; Xiao Y.; Wei X.; Pan J.; Duanmu D. Highly efficient CRISPR-mediated base editing in Sinorhizobium meliloti. Front. Microbiol. 2021, 12, 686008. 10.3389/fmicb.2021.686008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang H.; Zhang Y.; Wang W.-X.; Chen W.; Zhang X.; Huang X.; Chen W.; Ji Q. PAM-expanded Streptococcus thermophilus Cas9 C-to-T and C-to-G base editors for programmable base editing in mycobacteria. Engineering 2022, 15, 67–77. 10.1016/j.eng.2022.02.013. [DOI] [Google Scholar]
- Heo Y. B.; Hwang G.-H.; Kang S. W.; Bae S.; Woo H. M. High-fidelity cytosine base editing in a GC-rich Corynebacterium glutamicum with reduced DNA off-target editing effects. Microbiol. Spectr. 2022, 10, e03760-22 10.1128/spectrum.03760-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo Y.; Ge M.; Wang B.; Sun C.; Wang J.; Dong Y.; Xi J. J. CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1. Microb. Cell Fact. 2020, 19, 93. 10.1186/s12934-020-01345-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Volke D. C.; Martino R. A.; Kozaeva E.; Smania A. M.; Nikel P. I. Modular (de)construction of complex bacterial phenotypes by CRISPR/nCas9-assisted, multiplex cytidine base-editing. Nat. Commun. 2022, 13, 3026. 10.1038/s41467-022-30780-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jakociunas T.; Rajkumar A. S.; Zhang J.; Arsovska D.; Rodriguez A.; Jendresen C. B.; Skjødt M. L.; Nielsen A. T.; Borodina I.; Jensen M. K.; Keasling J. D. CasEMBLR: Cas9-facilitated multiloci genomic integration of in vivo assembled DNA parts in Saccharomyces cerevisiae. ACS Synth. Biol. 2015, 4, 1226–1234. 10.1021/acssynbio.5b00007. [DOI] [PubMed] [Google Scholar]
- Jessop-Fabre M. M.; Jakočiu̅nas T.; Stovicek V.; Dai Z.; Jensen M. K.; Keasling J. D.; Borodina I. EasyClone-MarkerFree: A vector toolkit for marker-less integration of genes into Saccharomyces cerevisiae via CRISPR-Cas9. Biotechnol. J. 2016, 11, 1110–1117. 10.1002/biot.201600147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Q.; Shi X.; Song L.; Liu H.; Zhou X.; Wang Q.; Zhang Y.; Cai M. CRISPR-Cas9-mediated genomic multiloci integration in Pichia pastoris. Microb. Cell Fact. 2019, 18, 144. 10.1186/s12934-019-1194-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Z.-H.; Wang F.-Q.; Wei D.-Z. Self-cloning CRISPR/Cpf1 facilitated genome editing in Saccharomyces cerevisiae. Bioresour. Bioprocess. 2018, 5, 36. 10.1186/s40643-018-0222-8. [DOI] [Google Scholar]
- Wang L.; Deng A.; Zhang Y.; Liu S.; Liang Y.; Bai H.; Cui D.; Qiu Q.; Shang X.; Yang Z.; He X.; Wen T. Efficient CRISPR-Cas9 mediated multiplex genome editing in yeasts. Biotechnol. Biofuels Bioprod. 2018, 11, 277. 10.1186/s13068-018-1271-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baisya D.; Ramesh A.; Schwartz C.; Lonardi S.; Wheeldon I. Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and-Cas12a guides in Yarrowia lipolytica. Nat. Commun. 2022, 13, 922. 10.1038/s41467-022-28540-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beeber D.; Chain F. J. crispRdesignR: A versatile guide RNA design package in R for CRISPR/cas9 applications. J. Genom. 2020, 8, 62. 10.7150/jgen.41196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slaymaker I. M.; Gao L.; Zetsche B.; Scott D. A.; Yan W. X.; Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science 2016, 351, 84–88. 10.1126/science.aad5227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfs J. M.; Hamilton T. A.; Lant J. T.; Laforet M.; Zhang J.; Salemi L. M.; Gloor G. B.; Schild-Poulter C.; Edgell D. R. Biasing genome-editing events toward precise length deletions with an RNA-guided TevCas9 dual nuclease. Proc. Natl. Acad. Sci. U.S.A. 2016, 113, 14988–14993. 10.1073/pnas.1616343114. [DOI] [PMC free article] [PubMed] [Google Scholar]




